title: Substitution with testosterone as aromatizable substrate for induction of follicular maturation, estradiol production and ovulation in a patient with 17 alpha-hydroxylase deficiency.
abstract: 17 alpha-Hydroxylase Deficiency (17 alpha-OHDS) is a rare defect of steroid biosynthesis, characterized by the inability to synthesize cortisol, androgens or estrogens, by the complete absence of follicular maturation, hypergonadotropic hypogonadism, primary amenorrhea and hypertension. Since the ovaries of such patients contain numerous primordial follicles, we hypothesized that the absence of spontaneous follicular maturation could be due to a lack of aromatizable substrate. To provide this substrate, testosterone was administered either by intra-ovarian injection or by vaginal administration. Ovarian stimulation was performed with human urinary gonadotropins. Follicular maturation and ovulation could be induced by this treatment, as determined from ultrasonography, the analysis of LH, estradiol and progesterone serum levels and the aspiration of oocytes from the mature follicles. Fertilization of these oocytes in vitro, however, did not succeed. We conclude that follicular maturation can be induced in 17 alpha-OHDS by gonadotropins when testosterone is provided as an aromatizable substrate and that estrogens are a necessary component of follicular maturation.
authors.affiliation: Department of Obstetrics and Gynecology, University of Erlangen, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Neuwinger
authors.forename: P
authors.initials: P
authors.lastname: Licht
authors.forename: B
authors.initials: B
authors.lastname: Munzer
authors.forename: T
authors.initials: T
authors.lastname: Sir-Petermann
authors.forename: E
authors.initials: E
authors.lastname: Siebzehnrübl
authors.forename: L
authors.initials: L
authors.lastname: Wildt
mesh_terms: D000312:Adrenal Hyperplasia, Congenital; D000328:Adult; D003345:Corticosterone / Q000097:blood; D004958:Estradiol / Q000096:biosynthesis*; D005260:Female; D006801:Humans; D006080:Ovarian Follicle / Q000187:drug effects*; D010060:Ovulation / Q000187:drug effects*; D011374:Progesterone / Q000097:blood; D012680:Sensitivity and Specificity; D013739:Testosterone / Q000097:blood / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D013739:Testosterone; D011374:Progesterone; D004958:Estradiol; D003345:Corticosterone